The Journal of Toxicological Sciences · 2019 · 15 citations · 27 references
Life SciencesCell BiologyPathobiologyAutophagyCarcinogenesisHepatologyAutophagy In DiseaseAutophagy ModulationAutophagy RegulationHepatic PathologyHepatic PathophysiologyLiver DiseaseCancer-associated AutophagyHepatic ApoptosisHepatic Lipid AccumulationHepatocellular Carcinoma PathogenesisHigh-fat Diet-induced Liver InjuryImmunohistochemical BiomarkersImmunohistochemical MarkersImmunohistochemical Staining
Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive deposition of droplets in hepatocytes. Patients with NAFLD can be at risk for nonalcoholic steatohepatitis, which can lead to hepatocellular carcinoma. Autophagy is a cellular pathway that is crucial for survival and homeostasis, and which protects against pathophysiological changes like obesity and cancer. We determined the expression of autophagy markers in preneoplastic hepatic lesions and the effects of an autophagy repressor chloroquine (CQ) or inducer amiodarone (AM) in a steatosis-related hepatocarcinogenesis model. Male F344 rats were fed a control diet or high fat diet (HFD), and subjected to initiation and promotion steps with N-nitrosodiethylamine injection at week 0 and a partial hepatectomy at week 3. Several HFD-fed rats were administered 0.1% CQ and 0.5% AM in their drinking water during week 2 and 8. CQ and AM did not improve HFD-induced obesity. AM, but not CQ, significantly decreased the number of glutathione S-transferase placental form-positive preneoplastic liver foci in the liver. Autophagosome markers LC3 and the LC3-binding protein p62 were heterogeneously expressed in the preneoplastic foci. CQ might inhibit autophagy by significantly increased p62/LC3 ratio, while AM might have a potential of inducing autophagy by showing an increased gene expression of the autophagy regulator, Atg5. These results suggest that preneoplastic lesions express autophagosome markers and that AM might decrease steatosis-related early hepatocarcinogenesis by potentially inducing autophagy in HFD-fed rats, while inhibition of autophagy by CQ did not alter the hepatocarcinogenesis. However, an immunohistochemical trial revealed a technical limitation in detecting autophagosome markers because there were variations in each preneoplastic lesion.
27
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
Autophagy regulates lipid metabolism
Rajat Singh, Susmita Kaushik, Yongjun Wang et al. · Nature · 2009 · 3.9K citations · Full text
Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice
Masaaki Komatsu, Satoshi Waguri, Masato Koike et al. · Cell · 2007 · 2.1K citations · Full text
Autophagy-deficient mice develop multiple liver tumors
Akito Takamura, Masaaki Komatsu, Taichi Hara et al. · Genes & Development · 2011 · 1.3K citations · Full text